Beyond Consulting is the evolution of my career as a clinical pharmacologist—an expansion beyond the lab into a space where science, strategy, and innovation intersect.

Rooted in both the arts and sciences, my path evolved into a vocation that integrates clinical expertise, entrepreneurial vision, and a deep creative drive.

– Stephanie Karzon Abrams Clin.Pharm.

Stephanie Karzon Abrams

Science and Spirit

I founded Beyond Consulting as a bridge between science, creativity, and community.

As a clinical neuropharmacologist, researcher, entrepreneur, and community builder, I bring a multidisciplinary approach to my work.

I am currently exploring the frontiers of psychedelics, neurology, women's health, integrative medicine, plant medicines, writing, public speaking, and policy work—an evolving journey that informs and inspires every project I undertake.

We can always chat about music too, as the Co-Creator of Public Secret music label, agency, and artist collective.

  • As an operations advisor, I excel at optimizing workflows, managing complex projects, and developing strategic plans. My ability to seamlessly blend analytical rigor with operational acumen, and infuse processes with creativity, makes me uniquely equipped to drive innovations and improvements across diverse environments.

    As a neuropharmacologist, I have a deep understanding of medical therapies, plant medicines, pre-clinical and clinical studies, as well as experience as a published researcher and writer.

    As a "Projector" (Human Design), I naturally perceive more efficient ways of doing things and am driven to guide others towards those solutions. My strong background in science and clinical practice ensures that my approach to problem-solving is both precise and well-informed. At the same time, my lifelong experience as a creative allows me to weave intuition, empathy, and innovation into my work, making my solutions not only effective but deeply human-centered.

  • My goal is to blend clinical excellence, creativity, and strategic mindset to provide comprehensive guidance and expert advice. Through open access education, research, and by supporting initiatives seeking to make a positive impact, I hope to help redefine the landscape of health and wellness.

  • -Traumatic brain injury

    -Spinal cord injury

    -Headache

    -Chronic pain

    -Women’s health

    -Hormonal and sexual health

  • Altered states and

    -Women’s hormone health

    -Physical therapy and rehabilitation

    -Athletic performance and help achieve flow state

    -Relationships, connection to self and to others

    -Music and dance

    —

    -Pharmacology & Chemistry
    of psychedelic compounds

    -The history of plant medicines within my own ancestral culture.

    -Stacking functional and medicinal plants

    -Optimizing the therapeutic experience for patients

    -Advocating for the betterment of patient care through educating and public speaking

    -Can altered states and mystical experiences make us better humans?

    -Dreams and the subconscious

    -Music as a language
    -Music as a psychedelic
    -Neuroscience of music

Research & Interests

PERSONAL WEBSITE
CONTACT
CURRENT PROJECTS

Curriculum Vitae

  • Post Graduate and Continuing Medical Education
    i. Certificate of Continuing Medical Education, Psychedelic Medicine Association-Managing Medical Risk in Patients Seeking Psilocybin Therapy

    ii. Certificate of Continuing Medical Education, Therapsil-Psilocybin Prescriber

    iii. Certificate of Continuing Medical Education, Numinus-Molecular Foundations: Psilocybin-Molecular Foundations: MDMA-Molecular Foundations: Ketamine

    iv. Certificate of Continuing Medical Education, Therapsil Prescriber for Psilocybin Therapy, Canada

    Masters of Science Clinical Pharmacology, Faculty of Medicine, University of Montreal
    i. Specializations: neurology, neuro/psychopharmacology
    ii. Research Fellowship: Intensive Care and Traumatic Brain Injury

    Bachelors of Science Biopharmaceutical Sciences, Faculty of Pharmacy, University of Montreal

    Neuropsychology and Linguistics, Faculty of Arts and Science, University of Montreal

    Minor Linguistics, University of Montreal

  • Founder, Beyond Consulting, 2022-present

    Fractional Clinical Director, Mystic Health, present

    Researcher, North Toronto Neurology, 2024- present

    Fractional Clinical Director, Modern Medicine Services, 2023-2025

    MDMA & Psilocybin Therapy Prescriber (independant), Therapsil Canada, 2023-present

    Research Director, Microdosing Collective 501c3, 2023-present

    Writer/Speaker, Freelance, 2023- present

    Researcher, Neurology Centre of TO, Numinus 2022- 2024

    Therapy Awareness & Market Dev. Advisor, Biosense Webster, Johnson & Johnson - 2018-2022

    Field Trainer & Educator, Biosense Webster, Johnson & Johnson - 2018-2022

    Sr. Clinical Specialist, Biosense Webster, Johnson & Johnson, 2016-2022

    Researcher & Clinical Study Coordinator, Intensive Care & Internal Medicine, Hôpital du Sacré-Coeur de Mtl, 2015-2017

  • TedX Speaker, 2024
    Psychedelics and Ancient Wisdom for Modern Healing

    Inner State Advisor, Share holder, 2025-
    A pre-clinical biotech company specializing in psychedelic producing fungi for drug discovery focused on enhancing women’s health and well-being.

    People Science, Advisor, Share holder, 2025-
    Technology enabled clinical research company addressing the need for affordable rigorous clinical science.

    Fungi Forward, Advisor, Share holder, 2025-
    Creating novel, data backed & side effect free therapeutics for the treatment of epilepsy and beyond.

    Psychedelic Medicine Association, Member, 2023-
    Society of physicians, therapists, and industry leaders looking to foster the therapeutic use of psychedelics.

    Therapsil, Non-profit, Member, 2023-
    TheraPsil is a non-profit coalition dedicated to helping Canadians in medical need access legal, psilocybin-assisted psychotherapy and medical psilocybin.

    American Society for Pharmacology and Experimental Therapies, Member, 2022
    Society founded by John Jacob Abel of John Hopkins University to promote growth of pharmacological research.

    Microdosing Collective, 501.c3, 2023 Research Director
    Initiative to promote harm reduction and access to low dose psychedelics.

    Psychedelics & Pain Association, Member, 2024-
    PPA advances science and public awareness towards a future where psychedelic medicines will significantly reduce chronic pain and suffering.

    Kawasaki Disease Foundation, 501c3, Board Member, 2021-2025
    Foundation supporting research and awareness for Kawasaki Disease as well as supporting individuals and families affected by KD.

    1. Persons with Spinal Cord Injury report peripherally dominant serotonin-like syndrome after use of serotonergic psychedelics, Karzon, S*†., Rabinovitch, B*†., Zafar, R., Aziz, A., Nielson, J.L‡, Lewis, EC†§ . Neurotrauma Reports. June 2023. NEUR-2023-0022.R1.

    2. Cognitive and motor function effects of antipsychotics in traumatic brain injury: a systematic review of preclinical studies, Gabrielle Cataford, Pharm.D, Laurie-Anne Monton, Pharm.D, Stephanie Karzon, B.Sc., M.Sc., D. Williamson, et al. Neurotrauma Reports. March 2024. NEUR-2023.0108

    3. A systematic review of interventions to facilitate extubation in patients difficult-to-wean due to delirium, agitation, or anxiety and a meta-analysis of the effect of dexmedetomidine, Sébastien Dupuis PharmD, MSc, Dave Brindamour BPharm, MSc, Stephanie Karzon BSc, MSc, Anne Julie Frenette BPharm, MSc, Emmanuel Charbonney MD, PhD, Marc M. Perreault PharmD, MSc, Patrick Bellemare MD, Lisa Burry PharmD & David R. Williamson BPharm, MSc, PhD, 9 Jan 23. PMID: 30674004.

  • https://www.stephaniekarzonabrams.com/press

A woman stands on stage giving a presentation at a conference, with large illuminated letters spelling 'SSHI' behind her and an audience seated in front.